Skip to main content

Capricor Therapeutics Inc (CAPR) Stock

Capricor Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Capricor Therapeutics Inc (CAPR), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $26.54. Over the past 52 weeks, it has ranged between $4.30 and $40.37. This places the current price at 65.7% of its 52-week high and 517.2% above its 52-week low. Recent trading volume was recorded at 7,018,373. The 14-day Relative Strength Index (RSI) stands at 92.92, suggesting overbought conditions. The stock is currently trading above its 50-day moving average of $6.84 by 288.01%. Similarly, it is above its 200-day moving average of $9.10 by 191.65%. The MACD histogram is 1.64, indicating bullish momentum (MACD Line: 1.79, Signal Line: 0.15).

52-Week Range

$40.37 - $4.30

-34.26% from high · +517.21% from low

Avg Daily Volume

5,052,017

20-day average

100-day avg: 2,210,065

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

PEG Ratio

0.00

Potentially undervalued

Price to Book

3.63

EV/EBITDA

-2.73

EPS (TTM)

-$1.75

Price to Sales

26.12

Beta

0.59

Less volatile than market

How is CAPR valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is CAPR's risk profile compared to the market?
With a beta of 0.59, Capricor Therapeutics Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 3.63 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-779.00%

EBITDA

$-84,921,808

Return on Equity

-107.80%

Return on Assets

-49.40%

Revenue Growth (YoY)

-7.90%

Earnings Growth (YoY)

0.00%

How profitable and efficient is CAPR's business model?
0 The operating margin of -779.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -107.80% and ROA at -49.40%, the company achieves moderate returns on invested capital.
What are CAPR's recent growth trends?
Capricor Therapeutics Inc's revenue declined by 7.90% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$290.8M

Revenue (TTM)

$11.13M

Revenue/Share (TTM)

$0.25

Shares Outstanding

45.72M

Book Value/Share

$1.83

Asset Type

Common Stock

What is CAPR's market capitalization and position?
Capricor Therapeutics Inc has a market capitalization of $290.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 45.72M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does CAPR's price compare to its book value?
Capricor Therapeutics Inc's book value per share is $1.83, while the current stock price is $26.54, resulting in a price-to-book (P/B) ratio of 14.47. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$20.70

22.00% downside potential

Analyst Recommendations

Strong Buy

2

Buy

8

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for CAPR?
10 analysts cover CAPR with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $20.70 implies -22.0% downside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on CAPR?
Current analyst recommendations:2 Strong Buy, 8 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 3, 2025, 07:33 PM

Technical Indicators

RSI (14-day)

92.92

Overbought

50-Day Moving Average

$6.84

288.01% above MA-50

200-Day Moving Average

$9.10

191.65% above MA-200

MACD Line

1.79

MACD Signal

0.15

MACD Histogram

1.64

Bullish

What does CAPR's RSI value tell investors?
The RSI (Relative Strength Index) for CAPR is currently 92.92, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret CAPR's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.79 above the signal line at 0.15, with histogram at 1.64. This bullish crossover suggests upward momentum is building. The wide histogram confirms strong momentum. The 50-day MA ($6.84) is below the 200-day MA ($9.10), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 4, 2025, 12:31 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CAPR and get notified when the price changes.

Stay Ahead of the Market with Capricor Therapeutics Inc Alerts

Set up price alerts for Capricor Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.